MM |
Multiple myeloma |
IMiDs |
immunomodulatory drugs |
PIs |
proteasome inhibitors |
IMWG |
International Multiple Myeloma Working Group |
CRS |
cytokine release syndrome |
FADD |
Fas-associated death domain |
ROS |
Reactive oxygen species |
HDACs |
histone deacetylases |
HATs |
histone acetyltransferases |
TMP |
tetramethylpyrazine |
CK |
Compound K |
SB |
Scutellaria baicalensis
|
TQ |
Thymoquinone |
EGCG |
Epigallocatechin-3-gallate |
DAPK2 |
death-associated protein kinase 2 |
VEGF |
vascular endothelial growth factor |
PDGF |
platelet-derived growth factor |
FGF |
fibroblast growth factor |
EGF |
epidermal growth factor |
TGFβ |
transforming growth factor beta |
MMPs |
matrix metalloproteinase’s |
TNF |
tumor necrosis factor |
Ang-1 |
angiopoietins |
uPAR |
urokinase receptor |
BM |
bone marrow |
BMM |
bone marrow microenvironment |
PCDC4 |
programmed cell death 4 |
GR |
glucocorticoid receptors |
ABM |
Agaricus blazei Murrill |
PBMCs |
peripheral blood mononuclear cells |